These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34120765)

  • 21. Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial.
    Theiss-Nyland K; Shakya M; Colin-Jones R; Voysey M; Smith N; Karkey A; Dongol S; Pant D; Farooq YG; Neuzil KM; Shrestha S; Basnyat B; Pollard AJ
    Clin Infect Dis; 2019 Mar; 68(Suppl 2):S67-S73. PubMed ID: 30845329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Typhoid fever vaccination strategies.
    Date KA; Bentsi-Enchill A; Marks F; Fox K
    Vaccine; 2015 Jun; 33 Suppl 3(Suppl 3):C55-61. PubMed ID: 25902360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An observer-blinded, cluster randomised trial of a typhoid conjugate vaccine in an urban South Indian cohort.
    Sahai N; Arunachalam DK; Morris T; Copas A; Samuel P; Mohan VR; Abraham V; Selwyn JA; Kumar P; Rose W; Balaji V; Kang G; John J
    Trials; 2023 Aug; 24(1):492. PubMed ID: 37537677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Phase II, Randomized, Double-blind, Controlled Safety and Immunogenicity Trial of Typhoid Conjugate Vaccine in Children Under 2 Years of Age in Ouagadougou, Burkina Faso: A Methods Paper.
    Laurens MB; Sirima SB; Rotrosen ET; Siribie M; Tiono A; Ouedraogo A; Liang Y; Jamka LP; Kotloff KL; Neuzil KM
    Clin Infect Dis; 2019 Mar; 68(Suppl 2):S59-S66. PubMed ID: 30845330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Field evaluation of typhoid conjugate vaccine in a catch-up campaign among children aged 9 months to 15 years in Sindh, Pakistan.
    Thobani RS; Yousafzai MT; Sultana S; Kazi AM; Jan M; Rafey A; Khan A; Irfan S; Ujjan IU; Brown N; Mårtensson A; Qamar FN
    Vaccine; 2022 Aug; 40(36):5391-5398. PubMed ID: 35945044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Typhoid Conjugate Vaccines: Advancing the Research and Public Health Agendas.
    Birkhold M; Mwisongo A; Pollard AJ; Neuzil KM
    J Infect Dis; 2021 Dec; 224(12 Suppl 2):S781-S787. PubMed ID: 34528085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children.
    Patel PD; Patel P; Liang Y; Meiring JE; Misiri T; Mwakiseghile F; Tracy JK; Masesa C; Msuku H; Banda D; Mbewe M; Henrion M; Adetunji F; Simiyu K; Rotrosen E; Birkhold M; Nampota N; Nyirenda OM; Kotloff K; Gmeiner M; Dube Q; Kawalazira G; Laurens MB; Heyderman RS; Gordon MA; Neuzil KM;
    N Engl J Med; 2021 Sep; 385(12):1104-1115. PubMed ID: 34525285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Programmatic Effectiveness of a Pediatric Typhoid Conjugate Vaccine Campaign in Navi Mumbai, India.
    Hoffman SA; LeBoa C; Date K; Haldar P; Harvey P; Shimpi R; An Q; Zhang C; Jayaprasad N; Horng L; Fagerli K; Borhade P; Daruwalla S; Dharmapalan D; Gavhane J; Joshi S; Rai R; Rathod V; Shetty K; Warrier DS; Yadav S; Chakraborty D; Bahl S; Katkar A; Kunwar A; Yewale V; Andrews JR; Bhatnagar P; Dutta S; Luby SP
    Clin Infect Dis; 2023 Jul; 77(1):138-144. PubMed ID: 36947143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infection Among Bangladeshi Children: A Protocol for a Phase IIIb Trial.
    Theiss-Nyland K; Qadri F; Colin-Jones R; Zaman K; Khanam F; Liu X; Voysey M; Khan A; Hasan N; Ashher F; Farooq YG; Pollard AJ; Clemens JD
    Clin Infect Dis; 2019 Mar; 68(Suppl 2):S74-S82. PubMed ID: 30845333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revised Global Typhoid Vaccination Policy.
    Bentsi-Enchill AD; Hombach J
    Clin Infect Dis; 2019 Feb; 68(Suppl 1):S31-S33. PubMed ID: 30767001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of typhoid fever transmission dynamic models and economic evaluations of vaccination.
    Watson CH; Edmunds WJ
    Vaccine; 2015 Jun; 33 Suppl 3(Suppl 3):C42-54. PubMed ID: 25921288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26-27 October 2016, Oxford, UK.
    Meiring JE; Gibani M;
    Vaccine; 2017 Sep; 35(38):5081-5088. PubMed ID: 28802757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of typhoid conjugate vaccine against culture-confirmed typhoid in a peri-urban setting in Karachi: A case-control study.
    Batool R; Tahir Yousafzai M; Qureshi S; Ali M; Sadaf T; Mehmood J; Ashorn P; Naz Qamar F
    Vaccine; 2021 Sep; 39(40):5858-5865. PubMed ID: 34465474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gavi Support for Typhoid Conjugate Vaccines: Moving From Global Investments to Country Introduction.
    Soble A; Patel Z; Sosler S; Hampton L; Johnson H
    Clin Infect Dis; 2020 Jul; 71(Suppl 2):S160-S164. PubMed ID: 32725236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of typhoid conjugate vaccine against culture-confirmed Salmonella enterica serotype Typhi in an extensively drug-resistant outbreak setting of Hyderabad, Pakistan: a cohort study.
    Yousafzai MT; Karim S; Qureshi S; Kazi M; Memon H; Junejo A; Khawaja Z; Ur Rehman N; Ansari MS; Ali R; Ujjan IU; Lohana HM; Memon NM; Hussain M; Nigar R; Bar-Zeev N; Qamar FN
    Lancet Glob Health; 2021 Aug; 9(8):e1154-e1162. PubMed ID: 34297962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persisting antibody responses to Vi polysaccharide-tetanus toxoid conjugate (Typbar TCV®) vaccine up to 7 years following primary vaccination of children < 2 years of age with, or without, a booster vaccination.
    Vadrevu KM; Raju D; Rani S; Reddy S; Sarangi V; Ella R; Javvaji B; Mahantshetty NS; Battu S; Levine MM
    Vaccine; 2021 Oct; 39(45):6682-6690. PubMed ID: 34625288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How Can the Typhoid Fever Surveillance in Africa and the Severe Typhoid Fever in Africa Programs Contribute to the Introduction of Typhoid Conjugate Vaccines?
    Jeon HJ; Im J; Haselbeck A; Holm M; Rakotozandrindrainy R; Bassiahi AS; Panzner U; Mogeni OD; Seo HJ; Lunguya O; Jacobs J; Okeke IN; Terferi M; Owusu-Dabo E; Dougan G; Carey M; Steele AD; Kim JH; Clemens JD; Andrews JR; Park SE; Baker S; Marks F
    Clin Infect Dis; 2019 Oct; 69(Suppl 6):S417-S421. PubMed ID: 31665772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parental acceptance of typhoid conjugate vaccine for children aged 6 months to 15 years in an outbreak setting of Lyari Town Karachi, Pakistan.
    Batool R; Yousafzai MT; Qureshi S; Muhammad S; Qazi I; Sadaf T; Ashorn P; Qamar FN
    Vaccine; 2023 Aug; 41(37):5376-5382. PubMed ID: 37463829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study.
    Mohan VK; Varanasi V; Singh A; Pasetti MF; Levine MM; Venkatesan R; Ella KM
    Clin Infect Dis; 2015 Aug; 61(3):393-402. PubMed ID: 25870324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Typhoid fever in children aged less than 5 years.
    Sinha A; Sazawal S; Kumar R; Sood S; Reddaiah VP; Singh B; Rao M; Naficy A; Clemens JD; Bhan MK
    Lancet; 1999 Aug; 354(9180):734-7. PubMed ID: 10475185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.